Surfactant effects on the viability and function of human mesenchymal stem cells: in vitro and in vivo assessment
Abstract Background Surfactant therapy has become the standard of care for preterm infants with respiratory distress syndrome. Preclinical studies have reported the therapeutic benefits of mesenchymal stem cells (MSCs) in experimental bronchopulmonary dysplasia. This study investigated the effects o...
Main Authors: | Chung-Ming Chen, Hsiu-Chu Chou, Willie Lin, Chris Tseng |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-08-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-017-0634-y |
Similar Items
-
Consecutive daily administration of intratracheal surfactant and human umbilical cord-derived mesenchymal stem cells attenuates hyperoxia-induced lung injury in neonatal rats
by: Hsiu-Chu Chou, et al.
Published: (2021-05-01) -
The therapeutic effect of mesenchymal stem cells on pulmonary myeloid cells following neonatal hyperoxic lung injury in mice
by: Ali Al-Rubaie, et al.
Published: (2018-06-01) -
Human placenta-derived mesenchymal stem cells attenuate established hyperoxia-induced lung injury in newborn rats
by: Hsiu-Chu Chou, et al.
Published: (2020-10-01) -
Anti-Tn Monoclonal Antibody Attenuates Hyperoxia-Induced Lung Injury by Inhibiting Oxidative Stress and Inflammation in Neonatal Mice
by: Chung-Ming Chen, et al.
Published: (2020-09-01) -
Maternal Tn Immunization Attenuates Hyperoxia-Induced Lung Injury in Neonatal Rats Through Suppression of Oxidative Stress and Inflammation
by: Chung-Ming Chen, et al.
Published: (2019-04-01)